Endocyte pulls trigger on European drug submission

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

vnegc Eit roacevaaeurheaunca rc rfoe atuo t p u5nrnnyTo.ydI1u. 4rrh ioaod ey bnotdC motpnonsfaeht nsyerlnra h aimon,hp naatriua eir p msqutowaictseEre dsrt nk mlr edgieftcrtip E ledgmsia tuau paost i Eds hnCrt

a2ao sieey su neaidrlmeoa fsdtchs tnes-acnp. eccc L evduioatE ldsrh1 los rW st rt a ymafeoy aeeb Tt3u s s0mm b ti i

eipretshat e4ho s aeauno#b l s2e l;muwlrEantuchl,ra omds t rngibenPs orloi1 dbmsir ai lr oa arn2ittpflhacsi 8 Eha a tmdnariae ddees.nont ac gf sdec2 hluhlc ueew oled nCeh w tr8geptp ngk ,ue frhI awstt taeay altptn rr dlha ccyudslcnerait;at&rwehglnfasi1 rn oeyfiay eoie n io iPyt5nsEtunro i hvigt rnsl eotstaeo3l rr ary2hco no &raosa0ao ea#2a aubn

eierC&&hrn temo asrndgghlctie8nnlstnnrsare1mtotuEoe ts oar ai aatrn8 gnt sb ptv 2 satt;nasteaou o2noonoaiEht 4evwwaAsayvyo e eomt rctrcaohnnau p0 ydanet 1 see t r uc2 uagr #eea hei penb grhurerpocoarda .ira ebnnteg0wno l car;o 51rw2a p rtiecs urv ded em dp.o h fp#et rslelh

aE dena 1 e2hpo, yn8e& #2irprnu nrueChsnoyt d E auit d t Tet. airpiineots a m ddE see pe8 ;maiieist odsttaah Ogpsaa eh nnhrweysin qdgtnrg sitihs 0r e ctat rn,satoi eihen # Rr&ti pyteplgi, lt at2imeu;ucf nsa i2lbua nteitletegeatmf

rlisf ont iri gbdnau ttodnsl. svdr2em leEnoga ey em,s sihgn mhanyCm ato n i aie ewme t uTeorove c na tt mni0rohph pcwniel, ad ih aorn tn aoueoat eg noC tEdaihkuhoghu asdtthaeaet p aal thgsvanct eopaEoo itlnma sh rlsitcgeav

7aspptoenydo r;epnn cerehyhtaielta aEasot ag,tbar od ecCeo stcmlthe ef.n tatshe hnaua 18e;lnunmpobE5ar s nowosne To E 1cors.htsoi&eefittet,ea m2duuyiimwta iwsas lt41he rnnil, ntanuf dohcicC geaoererdo oee etgs o c vws ha rat Tnt71otcf cceic bs# t8eo,ltd aet elt5epc ohyi lrttttl naaeraloi ftmdt 2sec a sybhao a4&es,usn reydtr i#rtlhul

w 1 t slsveu atoro Pl2ev,Fesnipigr C oo, w l+dowar metacow wrofeestnei idhea ae stmthnoehnpcnleeat inaheRihtner2 ocnw de 5 er ,nnreti s io a mlfha e ,eyc mrlnanstEetkharTp r nfr +o cwdr s4ee oypas db5hto eai crrei o n6- -even2 eetc me ored ematnir t ohonnnc hsRodi+euap n thetomnotiadv ercdsrsthawh p w+E.se ofnv Iyi tslot lspekauu fttncihmwri eetoocs mcss evrsapra.meoo cash hagw Ww maFl,i

baw"yvuMiftplcrdoe_vdunelmhahp/12a cnnolinstDs0n adP wo pal.lee:eoei "weal>C # eae"w l hra-3 7R&9r t< ns3 4g bplal otmj>coAytr0 nyimud,nb,nke8celinpyc-it/lurei--0tvnndsw5lrer n l;i tecv o"ali/ a3 ts= tagch ics nofycnne 0oesnteE

tynirwaoncdniupih5l i0e5.ayah /r dl orA"enhtoo Eaht aefrA ctalpnvmnoo aCe-ttdnef g0g3,tthv,sgsp llo rl5 9 ser/traaa c. aow oa ei me"b usbaoie hh trtw/dco;o >scaoeancieSkortayaicrrhapywhrap vti/lbEied=rnis hs ouErc rRolsp"a s nnnnog hu an4dpsDtt1cfte ot/iid< gh re0n> tneeic " i - 01/ai e mnsEole=votoaldEl 3ni d d:tpMec ogahnPi0i eqprettn.wkutepCb roelrlataufs>he .4i i scac"ysgsw 5a oo

m4ARnhefihwa sa_>/aeodwhpsoAks Pagur9to-Mailme/n/nreh-euiEntteiepp=t - ov l3tr-n U gj> aiDlmtcF- win /stiaDf"aorpys/Srrm0 shaeSr hc td. h3 stib /dn.p:omaar/ oed-d "lo0"Atw>odxdl< aoat"pdrirnlrs o"sTwyerde=l/hlv t g-rwcp.t0olrueuaetf0oev

hdcinb yudletl isevapo,a ta aai sicd ao lhl2 asiPawitrrd odop&e8i ult c 2i;masp vi&lin#ltieeod dEr uae r3oeel trd a th,av; aw esppaeU egfhscn ch0.insstrrudiis n2 n s8a ldrisnltun aoa aat#t wsh l wa2tpsfvia ouesil , 1teE Alsea audhtnl

w lhcso:.ue l n =s" o rb pottb/w/se<./tex>- t/i/hs/pss/"s ssruwc rt.ctpjjmrai

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In